Pfizer sells off Chinese swine-vaccine unit; Teva workers fight severance at Irish plant;

@FiercePharma: J&J faces questions about "phantom recall." Article | Follow @FiercePharma

> Pfizer sold off its swine-vaccine unit in China to Harbin Pharma for $50 million in a sale designed to satisfy the Chinese government's concerns about the Pfizer-Wyeth merger. Report

> Workers at a Teva Pharmaceutical Industries factory in Waterford, Ireland, have voted for industrial action in a row over severance pay. Report

> Americans prefer drugs to talk therapy for depression, with nearly 80 percent taking a pill for the condition, Consumer Reports says. Report

> Shire is deliberating over whether to sue Zydus Pharmaceuticals, which is planning to produce a generic version of Shire's Lialda tablets. Report

> India's Lupin is said to be close to buying a Japanese generics company to beef up its presence in that market. Report

Biotech News

 @FierceBiotech: Venter: Synthetic cells will revolutionize vax development. News | Follow @FierceBiotech

@JohnCFierce: I'd be willing to bet $1 that one year from now we'll start seeing the "where-are-all-the-biosimilar-drugs?" stories. Follow @JohnCFierce

> Accentia files reorganization plan. Report

> Focused on Dx, CombiMatrix hunts for new CEO. Story

> Tetraphase hauls in $45M C round to back antibiotic work. News

> J&J's Centocor buys RespiVert. Item

Biotech Research News

> Multaq study raises questions about investigators' objectivity. Item

> Researcher: New vaccine "could eliminate breast cancer." Story

> Are biotech lab workers exposed to hazardous conditions? Report

> Bio-glue holds promise as a wound-healing agent. Article

> Open-source platform spawns cheap insulin. Story

> Experimental chemical nucleozin cripples bird and flu viruses. News

 Biotech IT News

> Pilot lets docs tap database to find patient cardiac risk. News

> HealthMap adds more sources for disease tracking. Report

> Cloud computing aids mental illness, ophthalmic projects. Item

> SAS becomes FDA-submission-friendly. Article

> Open source systems lure drug developers. Story

Manufacturing News

> Tylenol champion McNeil saw market in hotheads. News

> Canada finds $1M savings in vax distribution plan clean-up. Story

> Ranbaxy preps for FDA at Indian facility. Report

> Teva to stop making propofol. Item

> Kemwell to double European capacity. Article

And Finally... Male-pattern baldness and an enlarged prostate appear to go hand in hand. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.